Medical Research
AI System Detects Pancreatic Cancer Signs Three Years Before Diagnosis
Mayo Clinic researchers have developed an AI system that identifies early warning signs of pancreatic cancer up to three years before formal diagnosis, potentially enabling earlier intervention and improved outcomes.
New Study Reveals How Cancer Reprograms Immune Cells, Offering Hope for Immunotherapy Breakthrough
A study uncovering how cancer cells reprogram immune cells to support tumor growth could improve immunotherapy response rates, which currently fail in 80% of patients.
Vitamin D Supplement Found to Boost Chemotherapy Efficacy in Breast Cancer Patients
A Brazilian clinical trial reveals that daily vitamin D supplementation improves outcomes for women undergoing standard chemotherapy for breast cancer, highlighting a low-cost intervention with global implications.
New Book Aims to Close Awareness Gap on Women's Heart Disease Symptoms
Cardiologist Arash Bereliani releases 'What About Her Heart' to educate the public on how heart disease presents differently in women, addressing a critical gap in recognition and timely diagnosis.
New Study Links Breast Tissue Aging to Increased Breast Cancer Risk in Older Women
Research mapping breast tissue changes with age explains higher breast cancer rates in older women and may guide new treatments.
Cardio Diagnostics Leverages AI and Biomarkers to Combat Cardiovascular Disease
Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) is advancing early detection of heart disease using a platform that combines artificial intelligence with multi-omic biomarker analysis, addressing the urgent need for innovation in cardiovascular care.
Stopping the ‘Silent Killer’: How to Check, Prevent and Manage High Blood Pressure
American Heart Association highlights that nearly half of U.S. adults have high blood pressure, many undiagnosed, and emphasizes lifestyle changes and monitoring to prevent heart disease and stroke.
Study Finds Exercise and Ibuprofen May Alleviate Chemo Brain in Cancer Patients
New research suggests that exercise and the common over-the-counter drug ibuprofen can help combat cognitive decline in cancer patients undergoing chemotherapy and radiation, a condition known as chemo brain.
Helus Pharma Partners with TARA Mind to Boost Veteran Recruitment in Phase 3 Depression Trial
Helus Pharma collaborates with TARA Mind and VETS to recruit veterans for its Phase 3 trial of HLP003 for major depressive disorder, aligning with a recent executive order on mental health.
Brain Health Shaped by Lifetime Mental, Physical, Environmental and Lifestyle Factors, New AHA Statement Says
A new American Heart Association scientific statement highlights that brain health is influenced by a range of factors across the entire lifespan, including mental health, sleep, environment, and social conditions, offering opportunities for early intervention to reduce the risk of stroke, cognitive decline, and dementia.
New Molecule Shows Promise for Glioblastoma Treatment, Clinical Trial Underway
Researchers at Brown University Health have identified a molecule that may alter glioblastoma treatment, with a clinical trial planning direct surgical delivery to the tumor.
8 Tips to Protect Your Vision as You Age, According to the National Eye Institute
The National Eye Institute offers eight actionable tips for maintaining eye health, emphasizing the importance of regular exams, healthy lifestyle choices, and managing chronic conditions to prevent vision loss.
Advanced Heart, Kidney and Metabolic Syndrome Linked to 30% Higher Cancer Risk, Study Finds
New research published in Circulation: Population Health and Outcomes reveals that later stages of cardiovascular-kidney-metabolic (CKM) syndrome are associated with a 25-30% increased risk of cancer, highlighting the need for integrated screening.
Novel Urine Test May Predict Bladder Cancer Treatment Response
Researchers have developed a urine test that detects tumor DNA to predict residual bladder cancer after surgery and assess immunotherapy effectiveness.
American Heart Association Mourns Passing of Pioneering Cardiologist Eugene Braunwald
The American Heart Association honors the legacy of Dr. Eugene Braunwald, whose seven decades of research transformed cardiovascular medicine, and highlights his enduring influence through mentorship and the Eugene Braunwald Academic Mentorship Award.
Physical Activity May Be Safer Than Thought for Children with Certain Heart Conditions, New Statement Says
The American Heart Association's new scientific statement suggests that with proper evaluation and monitoring, physical activity can be beneficial for children with cardiomyopathies or implantable cardioverter-defibrillators, shifting away from blanket restrictions.
Loneliness Identified as Risk Factor for Degenerative Heart Valve Disease
New research reveals that loneliness, distinct from social isolation, is associated with a significantly higher risk of developing degenerative heart valve disease, suggesting it could be a modifiable risk factor with important implications for prevention and treatment strategies.
NeuroOne Partners with University of Minnesota to Advance Targeted Epilepsy Treatment Platform
NeuroOne Medical Technologies is collaborating with the University of Minnesota to develop a brain drug delivery system that could revolutionize epilepsy treatment by delivering therapies directly to seizure sites, potentially improving efficacy while reducing side effects.
American Heart Association Awards $15 Million to Research Early Detection of Heart Valve Disease
A new $15 million research initiative led by three major medical institutions aims to transform heart valve disease care by focusing on early detection and prevention strategies for a condition affecting over 80 million people worldwide.
Tonix Pharmaceuticals Publishes Pharmacokinetic Study Supporting TONMYA's Mechanism for Fibromyalgia Treatment
Tonix Pharmaceuticals' peer-reviewed study demonstrates TONMYA's superior pharmacokinetic profile compared to oral cyclobenzaprine, supporting its use as the first new fibromyalgia treatment in over 15 years.
Analytical Validation Strengthens Soligenix Outlook as Pipeline Advances
A recent Zacks Small-Cap Research report highlights Soligenix's clinical progress and upcoming milestones, particularly in its phase 3 FLASH2 trial for cutaneous T-cell lymphoma treatment, reinforcing the company's strategic credibility and valuation potential.
Jacksonville Family Transforms Type 1 Diabetes Diagnosis Into Advocacy Through Community Initiative
A Jacksonville family's journey with their son's Type 1 diabetes diagnosis has evolved into Pablo's Pack T1D, a community initiative providing resources and support while participating in the Breakthrough T1D Walk to advance research toward a cure.
GeoVax Advances Mpox/Smallpox Vaccine Toward Phase 3 Trial Amid Global Supply Concerns
GeoVax Labs is preparing to initiate a pivotal Phase 3 trial for its GEO-MVA vaccine in the second half of 2026, addressing critical global supply constraints for orthopoxvirus vaccines while reporting a reduced net loss of $21.5 million for 2025.
Memory Beads Inspired by 116-Year-Old's Habit Launch to Support Alzheimer's Research
A new tactile brain health tool called Peter's Memory Beads, inspired by a 116-year-old man's daily routine, has launched with all proceeds supporting Alzheimer's Association research and services.
Soligenix Reports Positive Interim and Comparative Data for CTCL Treatment HyBryte
Soligenix announced consistent interim response rates from its phase 3 FLASH2 study and positive comparative results for HyBryte against Valchlor in cutaneous T-cell lymphoma, highlighting progress for a disease with limited treatment options.
Two Neuroscientists Awarded 2026 Ralph L. Sacco Scholarships for Brain Health Research
The American Academy of Neurology and the American Heart Association have awarded $150,000 scholarships to Sarah Kettlety and Cali McEntee to study concussion recovery in children and the effects of exercise on brain aging, respectively.
Lantern Pharma Seeks FDA Feedback on HARMONIC Trial Protocol Amendments for Lung Cancer Drug
Lantern Pharma has scheduled a Type C meeting with the FDA to discuss proposed changes to its Phase 2 HARMONIC trial for LP-300 in non-small cell lung cancer, focusing on EGFR Exon 21 L858R patients based on promising clinical data.
Oragenics Reports Early Progress in Phase IIa Trial of Intranasal Concussion Therapy
Oragenics Inc. has enrolled two patients and administered eight doses in its Phase IIa trial for ONP-002, a potential first-in-class intranasal treatment for mild traumatic brain injury, addressing a significant unmet medical need in a market with no FDA-approved pharmacological therapies.
GeoVax Advances Vaccine Programs Amid Global Health Crises Despite Financial Losses
GeoVax Labs reported significant progress in its mpox, COVID-19, and cancer vaccine programs during Q3 2025, positioning the company as a key player in addressing urgent public health needs while navigating financial challenges.
Astatine-211 Breakthrough Offers Targeted Cancer Treatment Alternative
Texas A&M University researchers have developed a cancer treatment using astatine-211 that targets malignant cells while sparing healthy tissue, representing a significant advancement in precision radiotherapy.